Logo

Stanford

Foresight Diagnostics Raises $12.5M in Series A to Commercialize MRD Detection Tech

The company, founded by Stanford University scientists, is advancing a technology called PhasED-Seq for cancer minimal residual disease detection.

AACR Presentations Highlight Power of Large Tumor Atlases in Studies of Cancer Progression
Premium

The talks focused on studies stemming from the Cancer Moonshot initiative's Human Tumor Atlas Network project, which is readying its first data release.

Maternal Blood Proteomic, Metabolomic Changes Could Predict Onset of Labor

About two to four weeks before labor starts, changes affecting the maternal metabolome, proteome, and immunome occur, a new study found.

DermTech Partners With Stanford School of Medicine to Study Chronic Skin Disorder

The partners will use DermTech's genomics technologies to identify biomarkers of hidradenitis suppurativa, a chronic and painful skin condition.

Amazon to Give Out $12M Under Next Phase of AWS Diagnostics Development Initiative

The company is planning to fund projects for SARS-CoV-2 testing, early disease detection, disease prognostics, and public health genomics projects.

Mar 25, 2021

Wild Animal Gut Microbiomes Reveal New Species, Ties to Host Traits

Mar 17, 2021

Genomics Plc Looks to Grow 'Genomic Prevention' With Polygenic Risk Scores
Premium

Mar 12, 2021

Stanford Team Profiling Omics of COVID-19 Vaccine Response
Premium

Mar 3, 2021

Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy
Premium

Feb 11, 2021

Fluidigm CEO Lays Out Plan for 'Durable' Diagnostics, Clinical Business Post-COVID
Premium

Feb 3, 2021

Stanford Team Developing Low-Cost, At-Home, Molecular COVID-19 Saliva Test
Premium

Jan 29, 2021

Stanford Launches Clinical Whole-Genome Sequencing for Inherited Cardiovascular Testing
Premium

Jan 27, 2021

Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy
Premium

Jan 19, 2021

Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores

Dec 28, 2020

COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020
Premium

Dec 17, 2020

Stanford Team Develops Mathematical Model of ctDNA Shedding to Predict Lung Cancer Tumor Size
Premium

Dec 7, 2020

Deepcell Closes $20M Series A Financing Round

Dec 2, 2020

Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents

Nov 30, 2020

FDA Reissues EUA for Stanford Health Care Coronavirus Test to Include Self-Collected Nasal Swabs

Nov 18, 2020

Single-Cell Atlas of Human Lung Identifies New, Known Cell Types

Nov 18, 2020

Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx
Premium

Oct 8, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform
Premium

Oct 7, 2020

Immunotherapy Response Prediction Improved by Baseline, On-Treatment Biomarker Combo
Premium

Sep 14, 2020

Endometrium Undergoes Gene Expression Shifts During Menstrual Cycle, Single-Cell Study Finds

Sep 10, 2020

GTEx Studies Provide Comprehensive Map of Genetic Regulatory Variation Across Cell Types, Tissues

Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.